Skip to content

Hydromol Ointment

by Alliance Pharmaceuticals Limited United Kingdom EUDAMED

Ref 613874Model Hydromol Ointment EMDN M9002

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-15036631007585 Basic UDI-DIDate25 Aug 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
Hydromol Ointment, 613874
Primary DI / UDI-DI
15036631007585
Basic UDI-DI
B-15036631007585
EMDN Code
M9002 Protective devices, lubricants and soothing devices (sprays, gels, fluids and creams)
Device Class
Class I
Market of Registration
Northern Ireland

Manufacturer details

EUDAMED SRN
GB-MF-000023165
Authorised representative
Alliance Pharma (Ireland) Ltd IE-AR-000022483

Other devices from Alliance Pharmaceuticals Limited

See all devices from Alliance Pharmaceuticals Limited →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 15036631007585|B-15036631007585 61 fields · synced 24 Oct 2026